Navigation Links
Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions
Date:10/22/2010

PITTSBURGH, Oct. 22 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the company and Mylan Charitable Foundation have awarded a collective $1.25 million to support two prominent West Virginia cultural institutions – The Clay Center for the Arts and Sciences of West Virginia and the State of West Virginia Division of Culture and History.

Heather Bresch, Mylan's president and a member of Mylan Charitable Foundation's board of directors said the awards reflect the long-standing commitment of Mylan and Mylan Charitable Foundation to support the communities we serve. "It's especially gratifying to continue our investments in West Virginia, where Mylan was founded nearly 50 years ago. Honoring our shared history and fostering the spirit of discovery, especially among children, will allow us to help keep ensuring a bright future for people in West Virginia and around the world."

The Clay Center received $750,000 from the Mylan Charitable Foundation and $250,000 from Mylan Inc. Funds from the Foundation will build the Center's permanent endowment; funds from Mylan will support programming and other initiatives.

The Center also celebrated the opening of a new, first-in-class science gallery called Mylan Explore-atory, named in recognition of Mylan Inc.'s support of the Clay Center. The gallery's inaugural exhibit, Toy Tech, will be on display through Jan. 16, 2011.

Clay Center President and CEO Judy Wellington said the funds will help the center further its mission. "We are incredibly grateful for this opportunity to enhance our ability to inspire creativity, learning and wonder."

The state's Division of Culture and History received $250,000 from the Mylan Charitable Foundation for the purpose of providing educational programming for children.

Division Commissioner Randall Reid-Smith said "This generous contribution will be wonderful for our education program. It will allow us to continue providing state-of-the-art educational materials and instruction opportunities. It will also provide funding to help with transportation for children around the state to visit the Museum."

The Division's State Museum also separately unveiled the first of two exhibits about Mylan. The first exhibit is a temporary one and will be on display through Nov. 28. The second exhibit will be permanent and will open some time next month. Both exhibits will walk people through Mylan's colorful and exciting history – from its founding in 1961 in White Sulphur Springs to its transformation into the powerful, global company it is today.

Mylan Inc. will underwrite bus trips in the spring that allow children in northern West Virginia to visit Mylan Explore-atory and the State Museum.

About Mylan

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.

About Mylan Charitable Foundation

Mylan Charitable Foundation is a 501(c)(3) organization whose mission is to support efforts to enhance the quality of life and meet unmet needs in and around the communities where Mylan operates – primarily working with child-related issues in the areas of education, social services and health – by encouraging self-sustaining and ongoing positive change.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
2. Mark W. Parrish Joins Mylans Board of Directors
3. WHO Withdraws Notice of Concern for Mylans Matrix Unit
4. Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
5. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
6. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
7. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
8. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
9. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
10. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
11. Mylan Confirms Four First-to-File Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... ... RegMedNet has produced a Spotlight series on “Cell Therapy Regulation” ... perspectives by leading experts on the unique regulatory challenges of stem cell medical ...
(Date:6/22/2017)... ... ... Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol (AMPH) test ... screening test at dairies and farms for raw commingled cow milk. The test was ... system. These systems are a combination incubator and reader in one. , “The AMPH ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadyl™, the ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... overseeing all service activities supporting EDETEK’s products including training, implementation, support, and client ... to his new role. He has previously held leadership roles for service providers ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):